Literature DB >> 30932162

Modulation of Cerebellar Activity in Schizophrenia: Is It the Time for Clinical Trials?

Andrea Escelsior1,2, Martino Belvederi Murri1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30932162      PMCID: PMC6737480          DOI: 10.1093/schbul/sbz017

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  6 in total

Review 1.  Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms.

Authors:  N C Andreasen; P Nopoulos; D S O'Leary; D D Miller; T Wassink; M Flaum
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

Review 2.  What Can Different Motor Circuits Tell Us About Psychosis? An RDoC Perspective.

Authors:  Vijay A Mittal; Jessica A Bernard; Georg Northoff
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

3.  Cerebellar atrophy in chronic schizophrenia.

Authors:  D R Weinberger; E F Torrey; R J Wyatt
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

Review 4.  The cerebellum and cognition.

Authors:  Jeremy D Schmahmann
Journal:  Neurosci Lett       Date:  2018-07-08       Impact factor: 3.046

5.  Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis.

Authors:  Jessica A Bernard; Joseph M Orr; Vijay A Mittal
Journal:  Neuroimage Clin       Date:  2017-03-06       Impact factor: 4.881

6.  The therapeutic potential of the cerebellum in schizophrenia.

Authors:  Krystal L Parker; Nandakumar S Narayanan; Nancy C Andreasen
Journal:  Front Syst Neurosci       Date:  2014-09-15
  6 in total
  1 in total

1.  Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology.

Authors:  Amira Ben Afia; Èlia Vila; Belén Ramos; Borja Garcia-Bueno; Karina S MacDowell; Aida Ormazabal; Juan C Leza; Josep M Haro; Rafael Artuch
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.